UltraGRO Advanced™ - Zheng Yang Biomedical Technology Co Ltd’s (Cambium’s strategic partner’s) Novel Cell Growth Culture Supplement

Background

The application of stem cells for heretofore untreatable chronic diseases and conditions is an exciting therapy today, specifically to treat cancer patients with conditions such as leukemia and lymphoma.  Research is also underway in and outside the U.S. to develop various sources and in certain cases less controversial sources of stem cells.  In addition, extensive research is also underway to explore their use in eventual therapies in such diverse fields as neurodegenerative diseases and conditions (e.g., Parkinson’s, Alzheimer's), brain and spinal cord injury, diabetes, immunotherapy, heart disease, macular degeneration and diabetic retinopathy, baldness, missing teeth, deafness, in certain transplantations, orthopedics, wound healing, infertility and HIV/AIDS and in veterinary applications to name just a few.

To do research on stem cell applications, they first need to be harvested and grown.  And regarding growth, in recent years human platelets processed into human platelet lysate products have been demonstrated as excellent culture mediums or supplements for the growth of stem cells.  The reason for this is in part is because of their rich concentration of naturally derived nutritive and regenerative components as discussed elsewhere in this website.

UltraGRO Advanced™ Cell Growth Supplement

Sold as UltraGRO Advanced™ currently for research purposes only by Cambium’s strategic partner Zheng Yang Biomedical Technology Co LTD, Taipei, Taiwan, this product utilizes Cambium’s Aurarix™ novel processed human platelet lysate sold as a premium cell growth supplement worldwide today.  Those interested in information or in learning more about UltraGRO Advanced™, please contact ZYBT directly.